Day

June 21, 2018

21
Jun
2018

Impact in More Ways Than One: Tony Coles on The Long Run Podcast

I’m happy to introduce the latest guest on The Long Run podcast — Tony Coles. He is the co-founder and CEO of Yumanity Therapeutics, a Cambridge, Mass.-based company doing drug discovery work against neurodegenerative diseases. That means Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (Lou Gehrig’s disease). This is a fascinating time to be focused on neurodegenerative diseases. The...
Read More